DK1345910T3 - Quinazoline derivatives, drugs containing the compounds, their use and process for their preparation - Google Patents

Quinazoline derivatives, drugs containing the compounds, their use and process for their preparation

Info

Publication number: DK1345910T3
Authority: DK; Denmark
Prior art keywords: compounds; preparation; quinazoline derivatives; drugs containing; drugs
Prior art date: 2000-12-20

Application number

DK01271363T

Other languages

Danish (da)

Inventor

Anke Baum

Frank Himmelsbach

Elke Langkopf

Stefan Blech

Birgit Jung

Flavio Solca

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-12-20

Filing date

2001-12-12

Publication date

2009-07-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7667887&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1345910(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-12-12 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2009-07-20 Application granted granted Critical

2009-07-20 Publication of DK1345910T3 publication Critical patent/DK1345910T3/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Medicinal Preparation (AREA)

DK01271363T 2000-12-20 2001-12-12 Quinazoline derivatives, drugs containing the compounds, their use and process for their preparation DK1345910T3 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10063435A DE10063435A1 (en)	2000-12-20	2000-12-20	Chinazoline derivatives, pharmaceuticals containing these compounds, their use and process for their preparation
PCT/EP2001/014569 WO2002050043A1 (en)	2000-12-20	2001-12-12	Quinazoline derivatives, medicaments containing said compounds, their utilization and method for the production thereof

Publications (1)

Publication Number	Publication Date
DK1345910T3 true DK1345910T3 (en)	2009-07-20

Family

ID=7667887

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01271363T DK1345910T3 (en)	2000-12-20	2001-12-12	Quinazoline derivatives, drugs containing the compounds, their use and process for their preparation

Country Status (39)

Country	Link
EP (2)	EP2112140A1 (en)
JP (1)	JP3827641B2 (en)
KR (1)	KR100852102B1 (en)
CN (1)	CN1277822C (en)
AR (1)	AR040524A1 (en)
AT (1)	ATE430136T1 (en)
AU (2)	AU2002219174B2 (en)
BE (1)	BE2014C009I2 (en)
BG (1)	BG66139B1 (en)
BR (1)	BRPI0116266B8 (en)
CA (1)	CA2432428C (en)
CY (2)	CY1109290T1 (en)
CZ (1)	CZ302721B6 (en)
DE (2)	DE10063435A1 (en)
DK (1)	DK1345910T3 (en)
EA (1)	EA006317B1 (en)
EE (1)	EE05244B1 (en)
ES (1)	ES2326617T3 (en)
FR (1)	FR14C0009I2 (en)
HR (1)	HRP20030504B1 (en)
HU (2)	HU228874B1 (en)
IL (2)	IL156277A0 (en)
LT (1)	LTC1345910I2 (en)
LU (1)	LU92370I2 (en)
ME (1)	ME02777B (en)
MX (1)	MXPA03005559A (en)
MY (1)	MY136086A (en)
NO (3)	NO325672B1 (en)
NZ (1)	NZ526918A (en)
PL (1)	PL214798B1 (en)
PT (1)	PT1345910E (en)
RS (1)	RS50860B (en)
SI (1)	SI1345910T1 (en)
SK (1)	SK287573B6 (en)
TW (1)	TWI295992B (en)
UA (1)	UA74614C2 (en)
UY (1)	UY27078A1 (en)
WO (1)	WO2002050043A1 (en)
ZA (1)	ZA200304141B (en)

Families Citing this family (91)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MEP45508A (en)	1999-06-21	2011-02-10	Boehringer Ingelheim Pharma	Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof
US7019012B2 (en)	2000-12-20	2006-03-28	Boehringer Ingelheim International Pharma Gmbh & Co. Kg	Quinazoline derivatives and pharmaceutical compositions containing them
DE10204462A1 (en) *	2002-02-05	2003-08-07	Boehringer Ingelheim Pharma	Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
US6924285B2 (en)	2002-03-30	2005-08-02	Boehringer Ingelheim Pharma Gmbh & Co.	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
US20040044014A1 (en)	2002-04-19	2004-03-04	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof
DE10221018A1 (en) *	2002-05-11	2003-11-27	Boehringer Ingelheim Pharma	Use of inhibitors of EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) / prostatic hypertrophy
PE20040945A1 (en) *	2003-02-05	2004-12-14	Warner Lambert Co	PREPARATION OF SUBSTITUTED QUINAZOLINES
US7223749B2 (en)	2003-02-20	2007-05-29	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
DE10307165A1 (en) *	2003-02-20	2004-09-02	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
US20050043233A1 (en) *	2003-04-29	2005-02-24	Boehringer Ingelheim International Gmbh	Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
DE10334226A1 (en) *	2003-07-28	2005-02-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Use of tyrosine kinase inhibitors for the treatment of inflammatory processes
GB0317665D0 (en)	2003-07-29	2003-09-03	Astrazeneca Ab	Qinazoline derivatives
US7569577B2 (en)	2003-09-16	2009-08-04	Astrazeneca Ab	Quinazoline derivatives as tyrosine kinase inhibitors
US7456189B2 (en)	2003-09-30	2008-11-25	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
DE10349113A1 (en)	2003-10-17	2005-05-12	Boehringer Ingelheim Pharma	Process for the preparation of aminocrotonyl compounds
RS52119B (en) *	2004-05-06	2012-08-31	Warner-Lambert Company Llc	4-phenylamino-HINAZOLIN-6-IL-STARCHES
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (en)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	INDOLINONE DERIVATIVES FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
WO2006081741A1 (en) *	2005-02-05	2006-08-10	Piaoyang Sun	Quinazoline compounds or their medical salts and preparation and medical usage thereof
KR100832593B1 (en) *	2005-11-08	2008-05-27	한미약품 주식회사	Quinazoline derivatives as an signal trnasduction inhibitor and method for the preparation thereof
EP1948180B1 (en)	2005-11-11	2013-03-13	Boehringer Ingelheim International GmbH	Combination treatment of cancer comprising egfr/her2 inhibitors
EP3173084B1 (en) *	2005-11-11	2019-10-23	Boehringer Ingelheim International GmbH	Quinazoline derivatives for the treatment of cancer diseases
PL1981863T3 (en)	2006-01-26	2013-03-29	Boehringer Ingelheim Int	Process for preparing aminocrotonylamino-substituted quinazoline derivatives
SI2068880T1 (en) *	2006-09-18	2012-08-31	Boehringer Ingelheim Int	Method for treating cancer harboring egfr mutations
EP1921070A1 (en)	2006-11-10	2008-05-14	Boehringer Ingelheim Pharma GmbH & Co. KG	Bicyclic heterocycles, medicaments comprising them, their use and process for their preparation
WO2008095847A1 (en)	2007-02-06	2008-08-14	Boehringer Ingelheim International Gmbh	Bicyclic heterocycles, drugs containing said compounds, use thereof, and method for production thereof
WO2009098061A1 (en)	2008-02-07	2009-08-13	Boehringer Ingelheim International Gmbh	Spirocyclic heterocycles, medicaments containing said compounds, use thereof and method for their production
WO2009138781A1 (en)	2008-05-13	2009-11-19	Astrazeneca Ab	Fumarate salt of 4- (3-chloro-2-fluoroanilino) -7-methoxy-6- { [1- (n-methylcarbamoylmethyl) piperidin- 4-yl] oxy}quinazoline
PE20100252A1 (en)	2008-06-06	2010-04-12	Boehringer Ingelheim Int	NEW SOLID PHARMACEUTICAL FORMULATIONS INCLUDING 4 - [(3-CHLORO-4-FLUOROPHENYL) AMINO DIMALEATE] -6 - {[4- (N, N-DIMETHYLAMINO) -1-OXO-2-BUTEN-1-IL] AMINO } -7 - ((S) -TETRAHIDROFURAN-3-ILOXI) -QUINAZOLINA
US8426430B2 (en)	2008-06-30	2013-04-23	Hutchison Medipharma Enterprises Limited	Quinazoline derivatives
US8648191B2 (en)	2008-08-08	2014-02-11	Boehringer Ingelheim International Gmbh	Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them
KR101703941B1 (en) *	2008-11-10	2017-02-07	내셔날 헬스 리서치 인스티튜트	Fused Bicyclic and Tricyclic Pyrimidine Compounds as Tyrosine Kinase Inhibitors
WO2010081817A1 (en)	2009-01-14	2010-07-22	Boehringer Ingelheim International Gmbh	Method for treating colorectal cancer
US20120136004A1 (en) *	2009-05-14	2012-05-31	Boehringer Ingelheim International Gmbh	New combination therapy in treatment of cancer and fibrotic diseases
EP2647375A1 (en)	2009-05-14	2013-10-09	Boehringer Ingelheim International Gmbh	Combination of vargatef and dabigatran for the treatment of oncological and fibrotic diseases
HRP20191005T1 (en)	2009-07-06	2019-08-23	Boehringer Ingelheim International Gmbh	Process for drying of bibw2992, of its salts and of solid pharmaceutical formulations comprising this active ingredient
JP2013512882A (en)	2009-12-07	2013-04-18	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	BIBW2992 for use in the treatment of triple negative breast cancer
WO2011084796A2 (en) *	2009-12-21	2011-07-14	Qiang Zhang	Novel quinazoline derivatives
US20120107304A1 (en)	2010-04-27	2012-05-03	Boehringer Ingelheim International Gmbh	Combination therapy in treatment of oncological and fibrotic diseases
JP2013536244A (en)	2010-08-26	2013-09-19	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Administration method of EGFR inhibitor
JP5808818B2 (en) *	2010-11-25	2015-11-10	ラツィオファーム・ゲーエムベーハー	Novel salt and polymorphic forms of afatinib
KR20220031732A (en)	2011-03-04	2022-03-11	뉴젠 세러퓨틱스 인코포레이티드	Alkyne substituted quinazoline compound and methods of use
US8828391B2 (en)	2011-05-17	2014-09-09	Boehringer Ingelheim International Gmbh	Method for EGFR directed combination treatment of non-small cell lung cancer
CN102918029B (en) *	2011-05-17	2015-06-17	江苏康缘药业股份有限公司	4-phenylamino-6-butenamide-7-alkyloxy quinazoline derivatives, preparative method and use thereof
CN102838590B (en) *	2011-06-21	2014-07-09	苏州迈泰生物技术有限公司	Amino quinazoline derivative and application thereof in preparation of antineoplastic drugs
EP2753616A1 (en)	2011-10-06	2014-07-16	Ratiopharm GmbH	Crystalline forms of afatinib di-maleate
CN103073539B (en) *	2011-10-26	2016-05-11	齐鲁制药有限公司	4-(substituted benzene amino) quinazoline derivant and preparation method thereof, pharmaceutical composition and purposes
ME02648B (en)	2012-01-17	2017-06-20	Astellas Pharma Inc	PYRAZINCARBOXAMIDVERBINDUNG
CN103772380A (en) *	2012-10-23	2014-05-07	杨子娇	Type of compounds for treating narrow chamber angle and use of compounds
WO2014118197A1 (en)	2013-02-01	2014-08-07	Boehringer Ingelheim International Gmbh	Radiolabeled quinazoline derivatives
HK1213818A1 (en)	2013-04-05	2016-07-15	勃林格殷格翰国际有限公司	Therapeutic uses of empagliflozin
CA2812519A1 (en)	2013-04-05	2014-10-05	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
US11813275B2 (en)	2013-04-05	2023-11-14	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
PT2981271T (en)	2013-04-05	2019-02-19	Boehringer Ingelheim Int	Therapeutic uses of empagliflozin
SI2986304T1 (en)	2013-04-18	2022-04-29	Boehringer Ingelheim International Gmbh	Pharmaceutical composition, methods for treating and uses thereof
CN103254183B (en) *	2013-05-10	2015-11-11	苏州明锐医药科技有限公司	Ah method is for the preparation method of Buddhist nun
WO2014180271A1 (en) *	2013-05-10	2014-11-13	苏州明锐医药科技有限公司	Method for preparing afatinib and intermediate thereof
CN103254182A (en) *	2013-05-10	2013-08-21	苏州明锐医药科技有限公司	Method for preparing Afatinib
CN103242303B (en) *	2013-05-16	2015-03-25	苏州明锐医药科技有限公司	Afatinib preparation method
WO2014183560A1 (en) *	2013-05-16	2014-11-20	苏州明锐医药科技有限公司	Afatinib and preparation method of intermediate thereof
CN104513229A (en) *	2013-09-28	2015-04-15	正大天晴药业集团股份有限公司	Quinazoline derivatives and preparation method thereof
CN103755688B (en) *	2013-12-24	2015-11-18	江苏奥赛康药业股份有限公司	A kind of Ah method is for the preparation method of Buddhist nun's compound
US9242965B2 (en)	2013-12-31	2016-01-26	Boehringer Ingelheim International Gmbh	Process for the manufacture of (E)-4-N,N-dialkylamino crotonic acid in HX salt form and use thereof for synthesis of EGFR tyrosine kinase inhibitors
WO2015103456A1 (en)	2014-01-02	2015-07-09	Teva Pharmaceuticals International Gmbh	Crystalline forms of afatinib di-maleate
CN105315263B (en) *	2014-07-30	2018-11-27	正大天晴药业集团股份有限公司	The synthetic method of afatinib intermediate
EP3023421A1 (en)	2014-11-21	2016-05-25	Sandoz Ag	Crystalline forms of afatinib dimaleate
CN105801568B (en)	2015-01-15	2019-07-30	杭州普晒医药科技有限公司	One maleate crystal form of Afatinib and preparation method thereof and pharmaceutical composition
US10231973B2 (en)	2015-03-20	2019-03-19	Chai Tai Tianqing Pharmaceutical Group Co., Ltd.	Salts of quinazoline derivative and method for preparing the same
CN105175400B (en) *	2015-09-29	2018-04-10	河北神威药业有限公司	A kind of preparation method of afatinib intermediate
WO2017141271A1 (en) *	2016-02-17	2017-08-24	Sun Pharmaceutical Industries Ltd.	Stable pharmaceutical composition of afatinib
CN106442793B (en) *	2016-10-21	2019-05-24	河北神威药业有限公司	A kind of detection method of the intermediate for preparing Afatinib and its enantiomter
CN109922813A (en)	2016-11-10	2019-06-21	勃林格殷格翰国际有限公司	Pharmaceutical composition, treatment method and application thereof
TWI808958B (en)	2017-01-25	2023-07-21	美商特普醫葯公司	Combination therapy involving diaryl macrocyclic compounds
US11708335B2 (en)	2017-12-18	2023-07-25	Sterngreene, Inc.	Pyrimidine compounds useful as tyrosine kinase inhibitors
CN110437163A (en) *	2018-05-03	2019-11-12	斯特恩格林公司	Pyrimidines as tyrosine kinase inhibitor
CA3113241A1 (en)	2018-09-25	2020-04-02	Black Diamond Therapeutics, Inc.	Quinazoline derivatives as tyrosine kinase inhibitor, compositions, methods of making them and their use
CN109265449B (en) *	2018-11-07	2021-11-23	沈阳工业大学	EGFR and HER2 double-target tyrosine kinase inhibitor and preparation method and application thereof
CN113195000A (en)	2018-12-21	2021-07-30	第一三共株式会社	Combination of antibody-drug conjugates and kinase inhibitors
CN109824657A (en) *	2019-03-26	2019-05-31	石药集团中奇制药技术（石家庄）有限公司	Two maleic acid Afatinib novel crystal forms of one kind and its preparation method and application
KR20220047810A (en)	2019-08-15	2022-04-19	블랙 다이아몬드 테라퓨틱스, 인코포레이티드	Alkynyl Quinazoline Compounds
CN110590682A (en) *	2019-10-14	2019-12-20	重庆医科大学	A kind of method for preparing Afatinib impurity and prepared impurity
US20210161897A1 (en)	2019-11-12	2021-06-03	Astrazeneca Ab	Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer
JP2023510426A (en)	2020-01-20	2023-03-13	アストラゼネカ・アクチエボラーグ	Epidermal growth factor receptor tyrosine kinase inhibitors for treating cancer
US20210369709A1 (en)	2020-05-27	2021-12-02	Astrazeneca Ab	EGFR TKIs FOR USE IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER
CN121135654A (en) *	2021-09-30	2025-12-16	北京赛特明强医药科技有限公司	A quinazoline compound, a composition and its application
WO2023187037A1 (en)	2022-03-31	2023-10-05	Astrazeneca Ab	Epidermal growth factor receptor (egfr) tyrosine kinase inhibitors in combination with an akt inhibitor for the treatment of cancer
CA3249080A1 (en)	2022-04-28	2023-11-02	Astrazeneca Ab	Condensed bicyclic heteroaromatic compounds and their use in the treatment of cancer
WO2023209090A1 (en)	2022-04-28	2023-11-02	Astrazeneca Ab	Bicyclic heteroaromatic compounds and their application in the treatment of cancer
US20240116926A1 (en)	2022-04-28	2024-04-11	Astrazeneca Ab	Heteroaromatic compounds
WO2023209088A1 (en)	2022-04-28	2023-11-02	Astrazeneca Ab	Bicyclic heteroaromatic compounds and their use in the treatment of cancer
IL317733A (en)	2022-06-27	2025-02-01	Astrazeneca Ab	Combinations involving epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EA001595B1 (en) *	1996-04-12	2001-06-25	Варнер-Ламберт Компани	Irreversible inhibitors of tyrosine kinases.
ZA986732B (en) *	1997-07-29	1999-02-02	Warner Lambert Co	Irreversible inhibitiors of tyrosine kinases
ZA986729B (en) *	1997-07-29	1999-02-02	Warner Lambert Co	Irreversible inhibitors of tyrosine kinases
WO2000051991A1 (en) *	1999-02-27	2000-09-08	Boehringer Ingelheim Pharma Kg	4-AMINO-QUINAZOLINE AND QUINOLINE DERIVATIVES HAVING AN INHIBITORY EFFECT ON SIGNAL TRANsSDUCTION MEDIATED BY TYROSINE KINASES
DE19911366A1 (en) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases
DE19908567A1 (en) *	1999-02-27	2000-08-31	Boehringer Ingelheim Pharma	New 4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors, polyps or respiratory or gastrointestinal diseases
DE19911509A1 (en) *	1999-03-15	2000-09-21	Boehringer Ingelheim Pharma	Bicyclic heterocycles, medicaments containing these compounds, their use and processes for their preparation
MEP45508A (en) *	1999-06-21	2011-02-10	Boehringer Ingelheim Pharma	Bicyclic heterocycles, medicaments containing these compounds, their use and methods for the production thereof
JP4939716B2 (en) *	2000-04-08	2012-05-30	ベーリンガーインゲルハイムファルマゲゼルシャフトミットベシュレンクテルハフツングウントコンパニーコマンディトゲゼルシャフト	Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and methods for their preparation

2000
- 2000-12-20 DE DE10063435A patent/DE10063435A1/en not_active Withdrawn
2001
- 2001-12-12 ME MEP-2008-595A patent/ME02777B/en unknown
- 2001-12-12 NZ NZ526918A patent/NZ526918A/en not_active IP Right Cessation
- 2001-12-12 PT PT01271363T patent/PT1345910E/en unknown
- 2001-12-12 IL IL15627701A patent/IL156277A0/en unknown
- 2001-12-12 EP EP09158964A patent/EP2112140A1/en not_active Withdrawn
- 2001-12-12 EA EA200300671A patent/EA006317B1/en not_active IP Right Cessation
- 2001-12-12 CN CNB018208665A patent/CN1277822C/en not_active Expired - Lifetime
- 2001-12-12 AU AU2002219174A patent/AU2002219174B2/en active Active
- 2001-12-12 CZ CZ20031930A patent/CZ302721B6/en not_active IP Right Cessation
- 2001-12-12 ES ES01271363T patent/ES2326617T3/en not_active Expired - Lifetime
- 2001-12-12 AT AT01271363T patent/ATE430136T1/en active
- 2001-12-12 UA UA2003076821A patent/UA74614C2/en unknown
- 2001-12-12 MX MXPA03005559A patent/MXPA03005559A/en active IP Right Grant
- 2001-12-12 HU HU0301852A patent/HU228874B1/en active Protection Beyond IP Right Term
- 2001-12-12 CA CA002432428A patent/CA2432428C/en not_active Expired - Lifetime
- 2001-12-12 SI SI200130916T patent/SI1345910T1/en unknown
- 2001-12-12 BR BRPI0116266A patent/BRPI0116266B8/en not_active IP Right Cessation
- 2001-12-12 EP EP01271363.2A patent/EP1345910B9/en not_active Expired - Lifetime
- 2001-12-12 KR KR1020037008246A patent/KR100852102B1/en not_active Expired - Lifetime
- 2001-12-12 WO PCT/EP2001/014569 patent/WO2002050043A1/en not_active Ceased
- 2001-12-12 AU AU1917402A patent/AU1917402A/en active Pending
- 2001-12-12 EE EEP200300300A patent/EE05244B1/en active Protection Beyond IP Right Term
- 2001-12-12 PL PL361798A patent/PL214798B1/en unknown
- 2001-12-12 SK SK771-2003A patent/SK287573B6/en not_active IP Right Cessation
- 2001-12-12 DK DK01271363T patent/DK1345910T3/en active
- 2001-12-12 HR HR20030504A patent/HRP20030504B1/en not_active IP Right Cessation
- 2001-12-12 RS YUP-496/03A patent/RS50860B/en unknown
- 2001-12-12 DE DE50114874T patent/DE50114874D1/en not_active Expired - Lifetime
- 2001-12-12 JP JP2002551540A patent/JP3827641B2/en not_active Expired - Lifetime
- 2001-12-17 UY UY27078A patent/UY27078A1/en not_active Application Discontinuation
- 2001-12-19 TW TW090131520A patent/TWI295992B/en active
- 2001-12-19 MY MYPI20015767A patent/MY136086A/en unknown
- 2001-12-19 AR AR20010105883A patent/AR040524A1/en active IP Right Grant
2003
- 2003-05-28 ZA ZA200304141A patent/ZA200304141B/en unknown
- 2003-06-03 IL IL156277A patent/IL156277A/en active Protection Beyond IP Right Term
- 2003-06-16 NO NO20032726A patent/NO325672B1/en active Protection Beyond IP Right Term
- 2003-06-19 BG BG107929A patent/BG66139B1/en unknown
2009
- 2009-07-23 CY CY20091100793T patent/CY1109290T1/en unknown
2014
- 2014-01-30 FR FR14C0009C patent/FR14C0009I2/en active Active
- 2014-01-31 LU LU92370C patent/LU92370I2/en unknown
- 2014-02-06 LT LTPA2014005C patent/LTC1345910I2/en unknown
- 2014-02-11 NO NO2014003C patent/NO2014003I2/en not_active IP Right Cessation
- 2014-02-12 CY CY2014008C patent/CY2014008I2/en unknown
- 2014-02-12 HU HUS1400005C patent/HUS1400005I1/en unknown
- 2014-02-18 BE BE2014C009C patent/BE2014C009I2/fr unknown
2022
- 2022-07-01 NO NO2022028C patent/NO2022028I1/en unknown

Also Published As

Publication number	Publication date
ES2326617T3 (en)	2009-10-16
NO325672B1 (en)	2008-07-07
BG66139B1 (en)	2011-07-29
CN1277822C (en)	2006-10-04
JP3827641B2 (en)	2006-09-27
HUP0301852A3 (en)	2008-03-28
IL156277A0 (en)	2004-01-04
MXPA03005559A (en)	2004-10-14
FR14C0009I2 (en)	2014-11-14
EP1345910B1 (en)	2009-04-29
BR0116266A (en)	2004-02-17
IL156277A (en)	2009-12-24
AR040524A1 (en)	2005-04-13
SI1345910T1 (en)	2009-08-31
ZA200304141B (en)	2004-04-15
HRP20030504B1 (en)	2011-09-30
HK1060571A1 (en)	2004-08-13
BE2014C009I2 (en)	2021-02-04
KR100852102B1 (en)	2008-08-13
SK7712003A3 (en)	2003-10-07
HUP0301852A2 (en)	2003-09-29
DE50114874D1 (en)	2009-06-10
EP2112140A1 (en)	2009-10-28
CN1481370A (en)	2004-03-10
WO2002050043A1 (en)	2002-06-27
NO2022028I1 (en)	2022-07-01
PL214798B1 (en)	2013-09-30
MEP59508A (en)	2011-05-10
RS50860B (en)	2010-08-31
EE05244B1 (en)	2009-12-15
ES2326617T9 (en)	2014-09-10
LTPA2014005I1 (en)	2022-05-25
EA200300671A1 (en)	2004-06-24
UY27078A1 (en)	2002-07-31
CY2014008I1 (en)	2014-07-02
BRPI0116266B8 (en)	2021-07-27
NO2014003I1 (en)	2014-06-02
PT1345910E (en)	2009-07-14
EA006317B1 (en)	2005-10-27
CY1109290T1 (en)	2014-07-02
EP1345910A1 (en)	2003-09-24
JP2004516283A (en)	2004-06-03
MY136086A (en)	2008-08-29
NO2014003I2 (en)	2015-10-19
AU2002219174B2 (en)	2007-09-06
YU49603A (en)	2006-05-25
LU92370I9 (en)	2019-01-17
NO20032726L (en)	2003-06-16
CZ20031930A3 (en)	2003-10-15
AU1917402A (en)	2002-07-01
DE10063435A1 (en)	2002-07-04
EP1345910B9 (en)	2014-06-04
TWI295992B (en)	2008-04-21
BG107929A (en)	2005-01-31
CA2432428A1 (en)	2002-06-27
PL361798A1 (en)	2004-10-04
SK287573B6 (en)	2011-03-04
CZ302721B6 (en)	2011-09-21
BRPI0116266B1 (en)	2017-10-31
ME02777B (en)	2011-10-10
EE200300300A (en)	2003-10-15
NO20032726D0 (en)	2003-06-16
ATE430136T1 (en)	2009-05-15
HU228874B1 (en)	2013-06-28
KR20030071787A (en)	2003-09-06
LU92370I2 (en)	2014-03-31
HUS1400005I1 (en)	2017-08-28
UA74614C2 (en)	2006-01-16
CY2014008I2 (en)	2015-12-09
LTC1345910I2 (en)	2022-06-10
HRP20030504A2 (en)	2005-06-30
NZ526918A (en)	2006-11-30
FR14C0009I1 (en)	2014-03-07
CA2432428C (en)	2009-09-01

Publication	Publication Date	Title
DK1345910T3 (en)	2009-07-20	Quinazoline derivatives, drugs containing the compounds, their use and process for their preparation
NO20024175D0 (en)	2002-09-02	Acetidine derivatives, their preparation and pharmaceutical compounds containing the same
NO20032733L (en)	2003-08-14	Diphenyllazetidinone derivatives, process for their preparation, drugs containing these compounds and their use
DK1180518T3 (en)	2007-05-21	5-pyridyl-1,3-azole compounds, process for their preparation and use thereof
DK1294682T3 (en)	2004-08-02	Acylphenylurea derivatives, processes for their preparation and their use as a drug
NO20014013D0 (en)	2001-08-17	16-halogenepotilone derivatives, processes for their preparation and their pharmaceutical use
NO20014603D0 (en)	2001-09-21	Tienopyrimidine Compounds, Their Preparation and Use
NO20011216L (en)	2001-05-09	Acetidine derivatives, their preparation and medicaments containing the compounds
IS6310A (en)	2002-03-19	Quinazoline derivatives for medicinal purposes
DK1218341T3 (en)	2005-12-12	Sulfonylcarboxamide derivatives, process for their preparation and their use as a drug
NO20015113L (en)	2001-12-19	New compounds, their preparation and use
NO20024742D0 (en)	2002-10-02	Heterocyclic compounds, their preparation and use
DK1083171T3 (en)	2004-08-09	Pyrazoline derivatives, their preparation and use as drugs
MXPA03000873A (en)	2003-06-06	Quinazoline derivatives, medicaments containing these compounds, their use, and methods for the production thereof.
DK1381605T3 (en)	2005-05-09	Mercaptoacetylamide derivatives, a process for their preparation and use
NO20016038L (en)	2002-02-11	Benzene derivatives, processes for their preparation and pharmaceutical compositions containing the same
NO20031273D0 (en)	2003-03-19	Substituted cinnamic acid guanidines, process for their preparation, their use as drug and drug containing the same
DK1674456T3 (en)	2008-10-27	New 1,4-benzothiazepine-1,1-dioxide derivatives with improved properties, process for their preparation, drugs containing these compounds and their use
DK1098891T3 (en)	2005-12-12	Polycyclic thiazolidin-2-ylidene amines, process for their preparation and their use as drugs
DK1118610T3 (en)	2002-12-16	Benzenesulfonamide derivatives, process for their preparation and pharmaceutical compositions containing the derivatives
NO20033120L (en)	2003-09-11	2-arylimino-2,3-dihydrotiazole derivatives, processes for their preparation and therapeutic use thereof
DK1086077T3 (en)	2004-08-02	New antiestrogens, methods for their preparation and their pharmaceutical use
DK1341758T3 (en)	2006-10-30	Coniosetin and its derivatives, process for the preparation and use of the same
DK1157020T3 (en)	2003-01-27	Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-ols, processes for their preparation and their use as a drug
DK1157014T3 (en)	2005-12-27	Polycyclic 2-amino-dihydrothiazole systems, process for their preparation and their use as drugs